Prevalence and risk factors for selection of quinolone-resistant escherichia coli strains in fecal flora of patients receiving quinolone therapy

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 3, 2009, Pages 1287-1289

  Yagci, D ^a   Yoruk, F ^a   Azap, A ^a   Memikoglu, O ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES MICROFLORA; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; QUINOLONES; RISK FACTORS;

EID: 62949181284     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01228-08     Document Type: Article

References (12)

1. Altunsoy, A., Ö. Ergönül, A. Azap, and İ Balik. 2006. Antibiotic use and resistance: outcome of a nationwide governmental antibiotic restriction policy, abstr. K-1415. 46th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA, 27 to 30 September 2006.
2. Arslan, H., O. K. Azap, O. Ergonul, and F. Timurkaynak. 2005. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J. Antimicrob. Chemother. 56:914-918.
3. Bearden, D. T., and L. H. Danziger. 2001. Mechanism of action of and resistance to quinolones. Pharmacotherapy 21:224-232.
4. Carratala, J., A. Fernandez-Sevilla, F. Tubau, M. A. Dominguez, and F. Gudiol. 1996. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob. Agents Chemother. 40:503-505.
5. CLSI. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Garau, J., M. Xercavins, M. Rodriguez-Carballeira, J. R. Gomez-Vera, I. Coll, D. Yidal, T. Llovet, and R. Bremon, 1999. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob. Agents Chemother. 43:2736-2741.
7. Goettsch, W., W. Van Pelt, N. Nagelkerke, M. G. R. Hendrix, A. G. M. Suiting, P. L. Petit, L. J. M. Sabbe, A. J. A. Griethuysen, and A. J. Neeling. 2000. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J. Antimicrob. Chemother. 46:223- 228.
8. Gupta, K., T. M. Hooton, and W. E. Stamm. 2005. Isolation of fluoroquin- olone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. J. Antimicrob. Chemother. 56:243-246.
9. Hillier, S., Z. Roberts, F. Dunstan, C. Butler, A. Howard, and S. Palmer. 2007. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J. Antimicrob. Chemother. 60: 92-99.
10. Kahlmeter, G., P. Menday, and O. Cars. 2003. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J. Antimicrob. Chemother. 52:1005-1010.
11. Perea, S., M. Hidalgo, A. Arcediano, M. J. Ramos, C. Gomez, J. Hornedo, C. Lumbreras, D. Folgueira, H. Cortes-Funes, and A. Rodriguez-Noriega. 1999. Incidence and clinical impact of fluoroquinolone-resistant Esdzmchia coli in the fecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. J. Antimicrob. Chemother. 44:117-120.
12. Zervos, M. J., E. Hershberger, D. P. Nicolau, D. J. Ritchie, L. K. Blackner, E. A. Coyle, A. J. Donnelly, S. F. Eckel, R. H. K. Eng, A. Hiltz, A. G. Kuyumjian, W. Krebs, A. McDaniel, P. Hogan, and T. J. Lubowski. 2003. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals. Clin. Infect. Dis. 37:1643-1648.